Viewing Study NCT07197112

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:45 PM
Ignite Modification Date: 2025-12-26 @ 10:45 PM
Study NCT ID: NCT07197112
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2025-09-19
Is NOT Gene Therapy: False
Has Adverse Events: False
Brief Title: Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy
Sponsor: Ruijin Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Graft Versus Host Disease Grade II-IV View
None Acute Graft vs Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gecacitinib View
None II~IV aGVHD View
None allogeneic hematopoietic stem cell transplantation View
None ruxolitinib View